Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Aug 2026.
- Largest single sale: $1.8M (6,500 shares) of Charles River Laboratories on Aug 11, 2026. Filing
- Last sale before this period: Feb 16, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Charles River Laboratories (CRL) | Chief Executive Officer, Director | Feb 21, 2018 | Aug 20, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 19, 2026, Charles River Laboratories: 528 shares given away. 1 filing: 1
- Aug 11, 2026, Charles River Laboratories: sold 6,500 shares for $1.8M, under a disclosed plan; 6,500 shares acquired by exercising options. 1 filing: 1
- Jun 5, 2026, Charles River Laboratories: 6,772 shares moved between their own holdings (some held indirectly). 1 filing: 1
- May 31, 2026, Charles River Laboratories: 378 shares withheld by the company for taxes. 1 filing: 1
- May 30, 2026, Charles River Laboratories: 1,204 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.